We identified 12 erythromycin-and clindamycin-resistant emm 90 group A streptococcus (GAS) isolates during a retrospective invasive disease survey in Hawaii. A comparison with 20 type-matched isolates showed all resistant isolates to be emm 90.4b with the constitutive or inducible macrolide-lincosamide-streptogramin B resistance phenotype (cMLS B or iMLS B ). All isolates had the same pulsed-field gel electrophoresis (PFGE) pattern, suggesting clonal spread.
The erythromycin resistance rate (ϳ3%) has been low among group A streptococcus (GAS) isolates in Hawaii, where impetigo, acute rheumatic fever, and clusters of necrotizing fasciitis have been reported (5) (6) (7) (8) (9) (10) ; G. Erdem, G. Matsuura, G. Wheelen, C. Mizumoto, D. Esaki, and P. V. Effler, presented at the XVIIth Lancefield International Symposium on Streptococci and Streptococcal Diseases, Porto Heli, Greece, 2008) . During a retrospective survey of 250 GAS cultures collected from patients with invasive GAS disease identified between the years 2005 and 2007, the reviews of the clinical information incidentally showed erythromycin and clindamycin resistance in five patients. emm typing of these isolates showed a single emm type: emm 90.4b. In addition to these five isolates, 15 additional isolates from individual patients with invasive disease were emm type 90.4b. The high percentage of invasive isolates (8%) belonging to this infrequent emm type and associated drug resistance prompted us to characterize the associated drug resistance patterns. We wanted to compare the resistance patterns among the isolates identified during this survey and other emm type 90 isolates identified from patients with noninvasive disease during our previous surveys. Of the 20 invasive GAS isolates, 12 were from blood cultures. Eight isolates were identified from wound cultures of inpatients with severe skin and soft tissue infections. Twelve additional emm type 90 pharyngeal isolates from our archived collection of 1,660 GAS isolates (collected from 1997 to 2007) were studied.
(Preliminary data were presented in part at the American Society of Tropical Medicine and Hygiene 58th Annual Meeting in November 2009.) emm sequencing (http://www.cdc.gov/ncidod/biotech/strep /strepblast.htm) was done for all isolates. Etest methodology (AB Biodisk, Piscataway, NJ) was used to determine MICs for erythromycin and clindamycin (2, 3) . The erythromycin-clindamycin double disk test was applied to resistant isolates. The "blunting" in the inhibition zone around the clindamycin disk next to the erythromycin disk was interpreted to be an inducible macrolide-lincosamide-streptogramin B resistance phenotype (iMLS B ), and susceptibility to clindamycin with no blunting indicated the M phenotype. The mef(A), erm(B), erm(A) (20) , and erm(TR) resistance genes and prtF1 were detected by PCR amplification (11, 19, 23, 24, 26, 27) . Pulsed-field gel electrophoresis (PFGE) was performed with a Chef-DR III apparatus (Bio-Rad) after SmaI digestion.
All (20 isolates Erythromycin or clindamycin is recommended as an alternative treatment of streptococcal pharyngitis in case of allergy to beta-lactams, and clindamycin could be used in combination with penicillin for treatment of severe streptococcal infections (12, 31) . Resistance of Sreptococcus pyogenes to macrolides and lincosamides has been reported, and overenthusiastic use of several macrolides may further increase this problem (14, 15, 19, 27, 28) . A few emm types, such as emm 4, 6, 12, 58, 75, 77, 89 and 114, have been associated with resistance (1, 4, 14, 17, 19, 24, 26, 28) . The emm type 90 isolates have not been associated with invasive GAS disease or with macrolide resistance (1, 4, 22, 25, 27, 30) . This emm type appeared to be common after 2006 among invasive GAS strains, although it has been infrequently identified during our previous studies (5-7, 8-10; Erdem et al., XVIIth Lancefield International Symposium on Streptococci and Streptococcal Diseases). Considering that we have previously showed a wide variety of rather infrequent continental U.S. emm types and low levels of resistance, the emergence of these clonal, drug-resistant and invasive strains in Hawaii is concerning (29) .
Macrolide resistance has been linked to invasiveness with possible introduction of drug resistance and virulence genes via lateral gene transfer (11) . This may explain the presence of drug-resistant and invasive strains in our study. Facinelli et al. described the drug-resistant intracellular streptococci escaping the effects of macrolides (11) . They found a high proportion of drug-resistant isolates to be PrtF1 positive, suggesting PrtF1 as a virulence factor (11) . In contrast, almost none of the invasive and drug-resistant strains in our study had this gene. This finding may be more in-line with PrtF1 association with persistent infection or carriage (11, 21) .
We do not know whether our strains have a higher invasion efficiency, since we have not done similar internalization and cell invasion assays. However, we have shown isolates harboring the rarely reported, constitutively expressed erm(TR) gene sharing the same PFGE pattern with the inducible resistant phenotypes after 2006 (17, 18, 20) . Expression of the erm genes can be constitutive and inducible, and the selective pressure of clindamycin may lead to selection of constitutively resistant derivatives with alterations in the attenuator of the erm(TR) gene (12, 15) . Point mutations in the erm regulatory region leading to constitutive methylase expression and high-level resistance due to the destabilization of the stem-loop structure have also been reported (17) . In pneumococci, constitutive expression of resistance was found to be due to deletions, duplications, or point mutations in the attenuator sequence, leading to the derepressed production of the methylase (15, 16) .
The single PFGE band difference between most of the drugresistant and -sensitive isolates was an interesting finding of our study. Macrolide resistance is more likely to occur from a horizontal gene transfer than a spontaneous chromosomal mutation when observed in a rapid spread of a single emm type (28) . In one study, the acquisition of the resistance phenotype was associated with the appearance of a new ϳ30-to 40-kb band in the PFGE pattern of a recipient macrolide-susceptible strain, suggesting a transposable element (13) . Further studies need to be done on the 250-kb genomic fragment of our drugresistant isolates to understand whether emm 90.4b developed drug resistance from a genomic insertion. Clonal spread of erythromycin-resistant strains belonging to a single emm type has been reported (14, 19, 24, 26) . Our study shows similar concerns of clonal emergence in Hawaii with this multidrugresistant emm type.
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